ClinicalTrials.gg
RecruitingNCT06525545EMOTAAUpdated Aug 2, 2024

Early MOtion Total Ankle Artroplasty

An interventional study of early mobilizzation of the ankle in Ankle Osteoarthritis, Ankle - Recurrent Dislocation and Cartilage Disease, sponsored by Istituto Ortopedico Rizzoli. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-08-02.

Sponsored by Istituto Ortopedico Rizzoli · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Oct 2025, 11 months ago, but the record still lists the study as recruiting.
  • Registered 8 months after the study started (first participant enrolled Oct 2023, registered Jul 2024).
  • Started Oct 2023; still recruiting 2 years 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Evaluate the clinical and radiographic results of patients undergoing total ankle arthroplasty and treated in the post-operative period in a randomized manner with early mobilization of the ankle joint or with cast immobilization for 3 weeks

02

Conditions studied

  • Ankle Osteoarthritis
  • Ankle - Recurrent Dislocation
  • Cartilage Disease
  • Ankle Arthropathy

Browse trials for

03

In context

Cartilage Diseases

74 studies on the registry are indexed under Cartilage Diseases; 6 are open to participants now.

This study's planned enrollment of 72 is above the median of 48 across 50 interventional studies indexed under Cartilage Diseases.

Browse Cartilage Diseases studies →

Lead sponsor

Istituto Ortopedico Rizzoli is the lead sponsor of 304 studies on the registry; 104 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients (aged between 18 and 80).
  • Male or female patients;
  • Signature of the informed consent for participation in the study;
  • Patients prepared and motivated to comply with the scheduled follow-up visits and the completion of the study questionnaires

Exclusion criteria

Exclusion Criteria:

  • main diagnosis other than osteoarthritis, history of ankle infection
  • need to carry out surgical interventions associated with total prosthesis ankle (e.g., calcaneal osteotomy, knee lowering osteotomy).

first metatarsal bone, supramalleolar osteotomy, etc.)

  • intraoperative complications (for example a malleolar fracture) which require a different post-operative protocol
  • peripheral vascular disease
  • marked osteoporosis of the ankle and foot
  • osteonecrosis of the talus
  • neurological disorders affecting the lower limb inability to understand study information or respond to questionnaires due to cognitive or linguistic deficits
  • patients who are pregnant or breastfeeding
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
72 participants (estimated)

Study arms

  • Experimental
    Mobilizzazione Precoce

    early motion of the ankle

    Procedure: early mobilizzation of the ankle

  • Active comparator
    Immobilizzazione Con Stivaletto Gessato

    standard treatment

    Procedure: early mobilizzation of the ankle

Interventions

  • Procedureearly mobilizzation of the ankle

    perform flexion-extension exercises of the operated ankle

06

What researchers measure

Primary outcomes

  1. AOFAS score

    The American Orthopedic Foot and Ankle Society Score is a semi-objective rating scale that evaluates ankle pain, motion and alignment and ranges from 0 to 100 points. 0 worst possible score, 100 best possible score

    Time frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery

  2. MOXFQ

    The MOXFQ is a 16-item instrument answered on a five-point Likert scale (each item is scored from 0 to 4, with 4 denoting 'most severe'). Scores for each item are summed to form three separate subscales representing underlying domains: walking/standing problems (seven items), foot pain (five items), and issues related to social interaction (four items). Raw scale scores are then each converted to a metric from 0 to 100, where 100 denotes the most severe.

    Time frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery

  3. SF-36 Questionnaire o Short Form-36 Health Survey

    The 36-Item Short Form Health Survey (SF-36) is a popular questionnaire for measuring the self- erception of quality of life in a given population of interest. Processing the answers of a participant comprises the calculation of 10 scores corresponding to 8 scales measuring several aspects of perceived health and 2 summary components (physical and mental)The scores range from 0 point (best) to 100 (worst).

    Time frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery

  4. VAS

    A Visual Analogue Scale (VAS) is a pain rating scales and ranges from 0 to 10 points

    Time frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery

  5. STTA - Sagittal TibioTalar Angle

    In a lateral weight-bearing radiograph, the saggittal Tibio Talar Angle is the angke between the rantomica axis of the tibia and the he longitudinal axis of the talus, this is determined by drawing a line connecting the midpoints of a line bisecting the talar neck and another line bisecting the talar body

    Time frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery

  6. Hindfoot Alignment - Saltzman view mesurament

    On the saltzman radiologial view is calculated thedistance between the axis of the tibia shaft and the contact point of the heel. Normal values -3 ± 7 mm

    Time frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery

  7. Lateral distal tibial angle - LDTA

    Lateral distal tibia angle (LDTA) is measured between the mid-diaphyseal line of the tibia and the line parallel to the distal tibial plafond. The lateral distal tibial angle has a norm of 89 degrees ± 3 degrees

    Time frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery

  8. Anterior distal tibial angle - ADTA

    The ADTA is formed by the mechanical axis of the tibia and the joint orientation line of the ankle in the sagittal plane and measures 80° ± 3° in the normal lower extremity

    Time frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery

  9. Tibio-Talar Angle - TTA

    The tibiotalar angle is between the anatomic axis of the tibia and the superior articular surface of the talar dome. The mean and standard deviation are: 88.7° ± 5.1°

    Time frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery

  10. Center of Rotation of Angulation CORA

    The CORA is the intersection of the mid-diaphyseal line and the line starting from the middle of the joint and perpendicular to the abnormal ADTA or LDTA. The CORA can be located at the joint line level (usually due to anatomical joint line malalignment or to ankle degeneration) or proximally (usually due to tibial deformities/fractures).

    Time frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery

  11. Gamma Angle

    Gamma angle (γ) is formed by intersection of line drawn through long axis of talar component with line drawn from posterior talar component through middle of talar neck.

    Time frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery

  12. T-T ratio (Tibio-talar Ratio)

    Tibiotalar ratio (TT ratio). A talar reference line is drawn parallel to the floor from the posterior talar point (defined as the intersection between the posterosuperior calcaneal cortex and the posterior subtalar articular surface) to the anterior talar point (vertical projection of the most anterior point of the talus onto the talar reference line). Next, the distal tibial axis is the line drawn between the midpoint of the distal tibial shaft measured 5 and 10 cm above the ankle. This divides the talar reference line into anterior and posterior segments. The TT ratio is the ratio of the length of the posterior segment of the talus (AC) to the longitudinal talar length (AB), expressed as a percentage. Normal value, 27% to 42%

    Time frame: 3, 6 weeks, 3 - 6 - 9 - 12 - 24 month from the surgery

07

Study locations

1 of 1 sites recruiting
  • Istituto Ortopedico Rizzoli
    Bologna, Italia 40135, Italy
    Recruiting
08

References and documents

Publications

  • Hintermann B, Knupp M, Zwicky L, Barg A. Total ankle replacement for treatment of end-stage osteoarthritis in elderly patients. J Aging Res. 2012;2012:345237. doi: 10.1155/2012/345237. Epub 2012 Jun 5. PubMed 22720158 ↗
  • Giannini S, Romagnoli M, O'Connor JJ, Catani F, Nogarin L, Magnan B, Malerba F, Massari L, Guelfi M, Milano L, Volpe A, Rebeccato A, Leardini A. Early clinical results of the BOX ankle replacement are satisfactory: a multicenter feasibility study of 158 ankles. J Foot Ankle Surg. 2011 Nov-Dec;50(6):641-7. doi: 10.1053/j.jfas.2011.06.003. Epub 2011 Aug 15. PubMed 21840736 ↗
  • Mosca M, Caravelli S, Vocale E, Maitan N, Grassi A, Massimi S, Fuiano M, Zaffagnini S. Clinical-radiological outcomes and complications after total ankle replacement through a lateral transfibular approach: a retrospective evaluation at a mid-term follow-up. Int Orthop. 2021 Feb;45(2):437-443. doi: 10.1007/s00264-020-04709-4. Epub 2020 Jul 14. PubMed 32666242 ↗
  • Onggo JR, Nambiar M, Phan K, Hickey B, Galvin M, Bedi H. Outcome after total ankle arthroplasty with a minimum of five years follow-up: A systematic review and meta-analysis. Foot Ankle Surg. 2020 Jul;26(5):556-563. doi: 10.1016/j.fas.2019.07.006. Epub 2019 Jul 25. PubMed 31420116 ↗
  • Izzo A, Di Gennaro D, Sgadari A, Coviello A, Marasco D, Balato G, Mariconda M, Bernasconi A. Periprosthetic joint infection in total ankle replacement: which are the current diagnostic criteria? Acta Biomed. 2023 Aug 3;94(4):e2023105. doi: 10.23750/abm.v94i4.14082. PubMed 37539613 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2023 (actual). Primary completion is estimated for Oct 2025, 24 months after the start.

Of 17 interventional studies with no phase under Cartilage Diseases, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 61. This study's planned 24 months is close to that.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 23, 2024
First posted
Jul 29, 2024
StartActual
Oct 31, 2023
Primary completionEst.
Oct 31, 2025
CompletionEst.
Oct 31, 2027
Last update
Aug 2, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06525545
Responsible party
Antonio Mazzotti (Principal Investigator, Istituto Ortopedico Rizzoli) — Principal investigator
First posted
Jul 29, 2024
Start date
Oct 31, 2023
Primary completion
Oct 31, 2025 (estimated)
Completion
Oct 31, 2027 (estimated)
Last update
Aug 2, 2024

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion